| Items 41 ~ 60 of 26060, Page 3 of 1303 |
| 41. |
Rising to the challenge of malaria eradication - 08/23/2019
WHO |
| 42. |
World Bank and WHO Statement on Partnership & Deployment of Financing to WHO for Ebola Response in DRC - 08/22/2019
WHO |
| 43. |
RSNA Announces New Global Learning Centers Program - 08/22/2019
Radiological Society of North America |
| |
OAK BROOK, Ill. (August 22, 2019) ? The Radiological Society of North America (RSNA) is launching a new RSNA Global Learning Centers (GLC) program beginning in 2020. By partnering with established radiology departments based in low- or middle-income countries to create the learning centers, RSNA aims to improve radiology education and patient care around the world. |
| 44. |
Merck Highlights New Data from Leading Lung Cancer Clinical Development Program at the IASLC 2019 World Conference on Lung Cancer - 08/22/2019
MERCK |
| |
Pooled Overall Survival (OS) Data from Three Trials with KEYTRUDA® (pembrolizumab) Plus Chemotherapy in Subgroup of Patients with Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Do Not Express PD-L1 / New KEYTRUDA Monotherapy Data in NSCLC Include Three-Year OS Data from Phase 3 KEYNOTE-024 and First-Time Data in Chinese Patients from Phase 3 KEYNOTE-042 |
| 45. |
Three years without a case of wild polio virus, Government of Nigeria warns against complacency - 08/21/2019
WHO |
| 46. |
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy - 08/20/2019
Radiological Society of North America |
| |
Pregnant women may be inadvertently exposed to a commonly used MRI contrast agent early in their pregnancy / Researchers analyzed data on U.S. pregnancies between 2006 and 2017 / Contrast agent exposure was seen in 5,457 of 4.69 million pregnancies, a number corresponding to one in 860 pregnancies |
| 47. |
Vaping Impairs Vascular Function - 08/20/2019
Radiological Society of North America |
| |
Vaping immediately impacts vascular function, even when the solution does not include nicotine / Researchers performed MRI exams on 31 healthy non-smoking adults before and after nicotine-free e-cigarette inhalation / In 2018 more than 3.6 million middle and high school students reported using e-cigarettes |
| 48. |
WHO Director-General underscores commitment to strengthening health in Pacific Islands - 08/18/2019
WHO |
| 49. |
Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality - 08/16/2019
Medtronic |
| |
Expanded TAVR Indication to Younger, More Active Patients Signals Groundbreaking Shift in the Future Treatment of Heart Valve Disease |
| 50. |
Medtronic Approved to Start Pivotal Trial to Evaluate New Extended Wear Infusion Set - 08/16/2019
Medtronic |
| |
Experimental Infusion Set Aims to Address Patient Burden with Comfort and Convenience Features for Insulin Pump Therapy |
| 51. |
WHO congratulates new UNAIDS Executive Director - 08/15/2019
WHO |
| |
The Director-General of the World Health Organization welcomes the appointment of Winnie Byanyima as the new Executive Director of UNAIDS. |
| 52. |
WHO statement urging governments to ban tobacco advertising, promotion and sponsorship at international expositions - 08/15/2019
WHO |
| 53. |
The surgeon who treats your ankle fracture is more important than previously recognized - 08/15/2019
American Academy of Orthopaedic Surgeons |
| |
Short-term complications after ankle fracture surgeries could lead to poor, long-term patient outcomes |
| 54. |
Burundi launches ebola vaccination campaign for health and front-line workers - 08/14/2019
WHO |
| 55. |
Abbott and Intoximeters Partner to Keep Roads Safer by Bringing Together Industry-leading Technology for Drug and Alcohol Testing - 08/14/2019
Abbott |
| |
Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers / Collaboration is a major step in keeping roads safer as recreational marijuana legalization accelerates[1] |
| 56. |
LYNPARZA® (olaparib) Phase 3 PAOLA-1 Trial Met Primary Endpoint as First-Line Maintenance Treatment with Bevacizumab for Advanced Ovarian Cancer - 08/14/2019
MERCK |
| |
AstraZeneca and Merck’s LYNPARZA, When Added to Standard-of-Care Bevacizumab, Significantly Reduced the Risk of Disease Progression or Death in Women Who Responded to Platinum-Based Chemotherapy |
| 57. |
It’s Never Too Late to Get More Exercise - 08/01/2019
American Cancer Society |
| |
Research shows that upping your exercise level can pay healthy dividends, even if you’re starting later in life. |
| 58. |
AI Improves Efficiency and Accuracy of Digital Breast Tomosynthesis - 07/31/2019
Radiological Society of North America |
| |
Researchers trained an AI system on large digital breast tomosynthesis (DBT) data sets to identify suspicious findings. / The system was tested by having 24 radiologists, including 13 breast subspecialists, each read 260 DBT examinations with and without AI assistance. / Cancer detection sensitivity and specificity increased, and reading times decreased. |
| 59. |
AI Showcase Expands and Relocates at RSNA 2019 - 07/31/2019
Radiological Society of North America |
| |
OAK BROOK, Ill. (July 31, 2019) ? The Radiological Society of North America (RSNA) will feature an expanded artificial intelligence (AI) presence at its 105th Scientific Assembly and Annual Meeting (RSNA 2019) at McCormick Place in Chicago. |
| 60. |
FDA Approves New Monotherapy Indication for Merck’s KEYTRUDA® (pembrolizumab) - 07/31/2019
MERCK |
| |
KEYTRUDA Now Approved for Recurrent Locally Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus in Patients Whose Tumors Express PD-L1 (CPS ≥10) With Disease Progression After One or More Prior Lines of Systemic Therapy |
